Oncology
1 drug is in development for Tuberous Sclerosis Complex.
- Companies
- 1
- Clinical trials
- 5
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Tuberous Sclerosis Complex pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| epidiolex | Jazz Pharmaceuticals plc (JAZZ) |
About this indication
Tuberous Sclerosis Complex context
Oncology·MeSH: Tuberous Sclerosis (D014402)
Also known as: Bourneville Disease, Bourneville Phacomatosis, Bourneville Pringle Disease, Bourneville Pringle's Disease, Bourneville's Disease, Cerebral Scleroses, Epiloia, Phakomatosis, Bourneville, Sclerosis Tuberosa, Sclerosis, Cerebral, Sclerosis, Tuberose, Sclerosis, Tuberous, Syndrome, Bourneville, Syndrome, Bourneville's
Frequently asked questions
How many drugs are in development for Tuberous Sclerosis Complex?
BioSniper tracks 1 drug in development for Tuberous Sclerosis Complex across 1 company.
How many clinical trials target Tuberous Sclerosis Complex?
There are 5 clinical trials targeting Tuberous Sclerosis Complex tracked by BioSniper.